ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

KASHAN KHAN MD

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,773Medicare Part D Prescriptions Filled, Including Refills

Rank: 24 out of 70

$393K Total Retail Price of All Prescriptions

Rank: 31 out of 70

539 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 539 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

14% of this provider’s 539 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 6,615 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 461 385 1 1
LISINOPRIL 328 269 2 3
CITALOPRAM HBR 300 235 3 16
OMEPRAZOLE 271 184 4 4
METOPROLOL TARTRATE 250 188 5 7
TRAMADOL HCL 246 172 6 17
WARFARIN SODIUM 239 221 7 10
FUROSEMIDE 235 205 8 6
AMLODIPINE BESYLATE 213 196 9 5
HYDROCODONE-ACETAMINOPHEN 201 109 S3 10 8
LEVOTHYROXINE SODIUM 173 106 11 2
GABAPENTIN 157 90 12 14
HYDROCHLOROTHIAZIDE 156 116 13 15
CARVEDILOL 155 129 14 19
ZOLPIDEM TARTRATE 133 85 15 23
CLOPIDOGREL 120 93 16 30
AZITHROMYCIN 110 74 17 40
PREDNISONE 98 70 18 52
PLAVIX 92 79 19 43
METFORMIN HCL 85 57 20 9
ATENOLOL 82 76 21 21
DONEPEZIL HCL 80 72 22 11
TAMSULOSIN HCL 80 65 22 29
GEMFIBROZIL 73 55 24 89
LEVOFLOXACIN 71 60 25 71
LISINOPRIL-HYDROCHLOROTHIAZIDE 70 56 26 58
CARBIDOPA-LEVODOPA 66 61 27 70
CYCLOBENZAPRINE HCL 62 29 R 28 103
MIRTAZAPINE 62 56 28 20
QUETIAPINE FUMARATE 61 61 30 37
SERTRALINE HCL 61 43 30 22
ADVAIR DISKUS 60 31 32 55
PROAIR HFA 57 45 33 80
POTASSIUM CHLORIDE 56 39 34 12
COMBIVENT 54 28 35 178
PROPRANOLOL HCL 54 29 35 165
NAMENDA 50 50 37 13
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 5, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.